AI assistant
Sending…
ArcticZymes Technologies — Director's Dealing 2010
Feb 22, 2010
3538_dirs_2010-02-22_703b6030-2f3d-4e29-a632-4833aeaf4d5c.html
Director's Dealing
Open in viewerOpens in your device viewer
Notification of trade primary insider
CSO of Biotec Pharmacon, Dr. Rolf E. Engstad, has
today purchased 50,000 shares in the Company at an
average price of NOK 4.09 per share.
Dr. Engstad holds 111,133 shares after this
transaction.
More from ArcticZymes Technologies
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Interim / Quarterly Report
2026
May 7
Call Transcript
2026
May 7
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 7
AGM Information
2026
May 6
AGM Information
2026
May 6
Investor Presentation
2026
May 4
Environmental & Social Information
2026
Apr 30
Annual Report
2026
Apr 30